World's Best Scientists 2026 revealed!
John D. Clements

John D. Clements

D-Index & Metrics

Immunology

D-Index
71
Citations
13715
World Ranking
2363
National Ranking
1133

John D. Clements publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John D. Clements sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 172 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John D. Clements D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Clements sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2002 - Fellow of the American Academy of Arts and Sciences
  • 1987 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

John D. Clements is affiliated with Tulane University in the United States and has contributed extensively to the field of medicine, with a focus on several subfields including epidemiology, radiology, nuclear medicine and imaging, infectious diseases, public health, environmental and occupational health, and immunology.

The main topics of their research encompass HIV research and treatment, monoclonal and polyclonal antibodies research, Escherichia coli research studies, multiple myeloma research and treatments, pregnancy and medication impact, child and adolescent health, and breastfeeding practices and influences.

Recent publications by John D. Clements include the following works:

  • Assuring Access to Safe Medicines in Pregnancy and Breastfeeding, 2021, Clinical Pharmacology & Therapeutics
  • Elevated Extracellular cGMP Produced after Exposure to Enterotoxigenic Escherichia coli Heat-Stable Toxin Induces Epithelial IL-33 Release and Alters Intestinal Immunity, 2021, Infection and Immunity
  • Enterotoxigenic Escherichia coli Heat-Stable Toxin Increases the Rate of Zinc Release from Metallothionein and Is a Zinc- and Iron-Binding Peptide, 2020, mSphere
  • A Randomized Trial of Topical Fibrinogen-Depleted Human Platelet Lysate Treatment of Dry Eye Secondary to Chronic Graft-versus-Host Disease, 2022, Ophthalmology Science
  • A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques, 2022, Science Immunology

Frequent collaborators in their work have included:

  • Natalya I. Motyka
  • Elizabeth B. Norton
  • Jacob P. Bitoun
  • Alan Sugar
  • Munira Hussain

John D. Clements has published in various established scientific venues, such as:

  • Clinical Pharmacology & Therapeutics
  • Infection and Immunity
  • Ophthalmology Science
  • Science Immunology
  • mSphere

They have been recognized with notable awards including being named a Fellow of the American Academy of Arts and Sciences in 2002 and a Fellow of the American Association for the Advancement of Science (AAAS) in 1987.

Best Publications

  • Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.

    Carol O. Tacket;Hugh S. Mason;Genevieve Losonsky;John D. Clements

  • Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

    Hugh S. Mason;Tariq A. Haq;John D. Clements;Charles J. Arntzen

  • Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection

    Terrence M. Tumpey;Mary Renshaw;John D. Clements;Jacqueline M. Katz

  • Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.

    Stephen L. Leib;David Leppert;John Clements;Martin G. Täuber

  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.

    Igor M. Belyakov;Zdenek Hel;Brian Kelsall;Vladimir A. Kuznetsov

  • Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

    Elizabeth B. Norton;Louise B. Lawson;Lucy C. Freytag;John D. Clements

  • Oral Immunogenicity of Human Papillomavirus-Like Particles Expressed in Potato

    Heribert Warzecha;Hugh S. Mason;Christopher Lane;Anders Tryggvesson

  • Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile Enterotoxin

    Ichiro Takahashi;Mariarosaria Marinaro;Hiroshi Kiyono;Raymond J. Jackson

  • Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune Responses

    Roberto A. Guerrero;Judith M. Ball;Sharon S. Krater;Susan E. Pacheco

  • Evidence for peripheral clearance of cerebral Aβ protein following chronic, active Aβ immunization in PSAPP mice

    Cynthia A Lemere;Edward T Spooner;John LaFrancois;Brian Malester

  • Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

    J. Holmgren;L. Bourgeois;N. Carlin;J. Clements

  • Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.

    Anna Lundgren;Louis Bourgeois;Nils Carlin;John Clements

  • Construction of a nontoxic fusion peptide for immunization against Escherichia coli strains that produce heat-labile and heat-stable enterotoxins.

    J D Clements

  • Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa

    Igor M. Belyakov;Vladimir A. Kuznetsov;Brian Kelsall;Dennis Klinman

  • Bacterial Toxins as Mucosal Adjuvants

    L. C. Freytag;J. D. Clements

  • IMMUNOGENIC CONJUGATES OF E. COLI HEAT LABILE SUBUNIT B ENTEROTOXIN

    Anderson Porter W;Clements John D

  • The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT.

    John D. Clements;Elizabeth B. Norton

  • Defending the mucosa: adjuvant and carrier formulations for mucosal immunity

    Louise B Lawson;Elizabeth B Norton;John D Clements

  • CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G).

    Monica M. McNeal;John L. VanCott;Anthony H. C. Choi;Matili Basu

  • Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein

    Anthony H.-C. Choi;Mitali Basu;Monica M. McNeal;John D. Clements

Frequent Co-Authors

Jay A. Berzofsky
Jay A. Berzofsky National Institutes of Health
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Brian L. Kelsall
Brian L. Kelsall National Institute of Allergy and Infectious Diseases
Lauren O. Bakaletz
Lauren O. Bakaletz The Ohio State University
Charles J. Arntzen
Charles J. Arntzen Arizona State University
Igor M. Belyakov
Igor M. Belyakov University of Michigan–Ann Arbor
Warren Strober
Warren Strober National Institute of Allergy and Infectious Diseases
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
M. Steven Oberste
M. Steven Oberste Centers for Disease Control and Prevention
Vijay T. John
Vijay T. John Tulane University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their knowledge beyond Immunology, online nursing degrees offer accessible pathways to rewarding healthcare careers. Many students with a non-nursing background can transition smoothly through programs like online ABSN programs for non nurses. These accelerated tracks allow faster entry into nursing roles, combining essential science education with clinical practice.

For licensed nurses seeking to advance further, accelerated nurse practitioner programs provide an excellent option. These programs focus on specialized clinical skills and leadership competencies, preparing graduates for advanced practice roles that often incorporate immunological knowledge.

If you’re looking for quicker entry points into nursing, accelerated BSN programs for non nurses offer flexible, demanding curricula that suit motivated students. Additionally, LPN programs easy to get into provide foundational nursing education and allow graduates to begin hands-on patient care sooner, which can be a stepping stone toward more advanced degrees.

Exploring these related online degrees can open myriad career pathways that are closely tied to immunology, providing practical applications of immune system knowledge in patient care, research, and healthcare leadership.

Best Scientists Citing John D. Clements

Trending Scientists

Recently Published Articles